通过在患有硬性硬化症危机的患者中存在的自身抗体刺激内衣素-1的产生
Pinchao Wang1, Dashan Wu1, Zexian Gong1
1Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Clinical immunology (Orlando, Fla.)
|February 16, 2025
概括
脊髓硬化症危机 (SRC) 患者的自身抗体刺激内皮细胞增加内皮林-1 (ET-1) 的产生. 这通过蛋白酶激活受体1 (PAR1) 和组织因子 (TF) 途径发生.
科学领域:
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 结核病危机 (SRC) 是结核病的一个严重并发症.
- 针对G蛋白结合受体 (GPCRs) 的自身抗体与SRC病原发生有关.
- 内皮细胞功能障碍在SRC中起着关键作用.
研究的目的:
- 研究来自SRC患者的自身抗体对人类微血管内皮细胞 (HMECs) 中内衣林-1 (ET-1) 生产的影响.
- 阐明SRC中ET-1失调背后的机制.
主要方法:
- 从SRC患者和健康人群中分离血清IgG.
- 用患者衍生的IgG治疗培养的HMECs.
- 对ET-1表达和释放的测量.
- 使用蛋白酶激活受体1 (PAR1) 抑制剂的抑制研究.
- 研究转录因子C-FOS/AP-1和组织因子 (TF) 的参与.
主要成果:
- SRC患者的IgG显著增加了ET-1表达和释放在HMECs中的时间和剂量依赖的方式.
- 通过PAR1抑制剂阻断了SRCIgG的作用.
- 一个PAR1激活剂的氨酸模仿了SRCIgG的作用.
- 鉴定出C-FOS/AP-1和TF是SRCIgG诱导的ET-1生成的媒介.
结论:
- 来自SRC患者的血清IgG刺激内皮细胞产生ET-1.
- 该机制涉及激活PAR1和与TF合作.
- 这些发现突出了潜在的途径,有助于SRC的血管并发症.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
457
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
457
01:25Antihypertensive Drugs: Direct Renin Inhibitors
474
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
474
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
130
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
130
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
573
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
573
01:17Hormonal Regulation of Blood Pressure
2.4K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.4K